<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02122666</url>
  </required_header>
  <id_info>
    <org_study_id>201311988</org_study_id>
    <nct_id>NCT02122666</nct_id>
  </id_info>
  <brief_title>Composition &amp; Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome</brief_title>
  <acronym>COMP-SR</acronym>
  <official_title>Modulating Physiologic Effects Of Phospholipid Metabolism In Obesity And Diabetes; AIM 4: Composition and Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators previous research has suggested that lipid (fatty) composition in the
      muscle cells of mice plays a key role in their insulin sensitivity. The purpose of this study
      is to determine whether these specific fat signatures translate to humans by comparing the
      muscle of healthy patients to those with pre-diabetes, or &quot;the metabolic syndrome&quot;.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Comp-SR study explores the role of lipid metabolism in key metabolic pathways in skeletal
      muscle. It is a translation of previous research done in mice studying the effects and
      functions of certain key enzymes involved in lipid metabolism found to be associated with
      insulin resistance. These enzymes are fatty acid synthase (FAS), choline/ethanolamine
      phosphotransferase 1 (CEPT1) and sarcoplasmic-endoplasmic reticulum ATPase (SERCA). Based on
      the investigators research, it appears that the activity and function of these enzymes
      determines the ratio of certain phospholipids in the sarcoplasmic reticulum (SR), namely
      phosphatidylethanolamine (PE) and phosphatidylcholine (PC). Furthermore, the investigators
      have found that the ratio of these phospholipids correlates with the mouse's sensitivity to
      insulin.

      Based on the muscle biopsies of four healthy persons, it was found that human muscle contains
      similar phospholipids and phospholipid ratios to mice. It is hypothesized that these
      phospholipid signatures may be predictive of the metabolic status of humans as well. The
      specific aims of this study are to determine if the composition and function of the
      sarcoplasmic reticulum is altered in persons with the metabolic syndrome compared to lean
      controls. This knowledge could provide new understanding of impediments to effective therapy,
      novel biomarkers of disease progression, and innovative treatment targets for diabetes.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sarcoplasmic Reticulum Composition</measure>
    <time_frame>Study Visit Week 4</time_frame>
    <description>We will take a muscle tissue sample from the subject's thigh (vastus lateralis) to quantify phosphatidylcholine to phosphatidylethanolamine ratio of the sarcoplasmic reticulum, as well as SERCA activity and FAS and CEPT1 quantity in the sample.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin Sensitivity</measure>
    <time_frame>Study visit week 4</time_frame>
    <description>We will perform an oral glucose tolerance test with insulin levels obtained at each time point to determine the Matsuda index, an estimation of insulin sensitivity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lean and Fat Body Mass</measure>
    <time_frame>Study Visit week 4</time_frame>
    <description>We will perform a Duel Energy X-ray absorptiometry (DEXA) scan to approximate lean and fat body mass of study subjects.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Metabolic Syndrome</arm_group_label>
    <description>Muscle biopsy to determine sarcoplasmic reticulum composition and function, Oral Glucose tolerance test with insulin levels at time points to determine Insulin sensitivity, DEXA scan to determine lean muscle and fat mass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Muscle biopsy to determine sarcoplasmic reticulum composition and function, Oral Glucose tolerance test with insulin levels at time points to determine Insulin sensitivity, DEXA scan to determine lean muscle and fat mass</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>muscle biopsy</intervention_name>
    <description>A member of the study team will obtain a small sample of muscle tissue from the patient's thigh (vastus lateralis muscle).</description>
    <arm_group_label>Metabolic Syndrome</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood and frozen tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic, community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Control subjects

        Inclusion:

          -  &lt;15 min exercise per day, &lt;2 days per week

          -  Age &gt;18 and &lt;65

          -  Body Mass Index (BMI) &lt;25

          -  Healthy by physical exam (patient is devoid of major acute or chronic illness)

          -  No significant abnormality in screening labs

        Exclusion:

          -  Currently on any significant prescription medications other than oral contraceptives
             in women

          -  Currently Pregnant

          -  Current Tobacco Use

        Subjects with the Metabolic Syndrome

        Inclusion:

          -  &lt;15 min exercise per day, &lt;2 days per week

          -  Age &gt;18 and &lt;65

          -  Body Mass Index (BMI) &gt;30

          -  Meet at least three of the following Adult Treatment Panel (ATP) III criteria for the
             metabolic syndrome:

               -  waist circumference &gt; or = 40 inches in men, &gt; or = 35 inches in women

               -  blood triglycerides &gt; or = 150 mg/dL

               -  blood HDL cholesterol &lt;40 mg/dL in men, &lt;50 in women

               -  blood pressure &gt; or = 130 mmHg systolic, or &gt; or = 85 mmHg diastolic

               -  fasting blood sugar &gt; or = 100 mg/dL

        Exclusion:

          -  Diagnosed with Type 2 diabetes, coronary artery disease, cancer, liver, lung, or
             kidney disease or any other major illness

          -  Currently on any significant prescription medications other than:

               -  oral contraceptives in women

               -  More than two standard medication for stage 1 hypertension in men or women (blood
                  pressure 140-159/90-99)

          -  Currently Pregnant

          -  Current Tobacco Use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clay F. Semenkovich, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janet B McGill, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://endo.wustl.edu/current-clinical-studies/</url>
    <description>Washington U in St. Louis, Endocrinology Current Clinical Studies</description>
  </link>
  <link>
    <url>http://endo.wustl.edu/clay-f-semenkovich-m-d/</url>
    <description>Clay F. Semenkovich, MD</description>
  </link>
  <link>
    <url>https://vfh.wustl.edu/</url>
    <description>Washington U in St. Louis; Research Participant Registry</description>
  </link>
  <reference>
    <citation>Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0. Erratum in: Lancet. 2013 Feb 23;381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added].</citation>
    <PMID>23245604</PMID>
  </reference>
  <reference>
    <citation>Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011 Feb 12;377(9765):557-67. doi: 10.1016/S0140-6736(10)62037-5. Epub 2011 Feb 3.</citation>
    <PMID>21295846</PMID>
  </reference>
  <reference>
    <citation>Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001 Sep 12;286(10):1218-27. Review.</citation>
    <PMID>11559268</PMID>
  </reference>
  <reference>
    <citation>Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc. 1995 Jun;27(6):875-81.</citation>
    <PMID>7658949</PMID>
  </reference>
  <reference>
    <citation>Funai K, Song H, Yin L, Lodhi IJ, Wei X, Yoshino J, Coleman T, Semenkovich CF. Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling. J Clin Invest. 2013 Mar;123(3):1229-40. doi: 10.1172/JCI65726. Epub 2013 Feb 8. Erratum in: J Clin Invest. 2013 Aug 1;123(8):3634.</citation>
    <PMID>23376793</PMID>
  </reference>
  <reference>
    <citation>McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 1992 Oct 30;258(5083):766-70.</citation>
    <PMID>1439783</PMID>
  </reference>
  <reference>
    <citation>Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev. 2006 Jan;86(1):205-43. Review.</citation>
    <PMID>16371598</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2014</study_first_submitted>
  <study_first_submitted_qc>April 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2014</study_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Metabolic Syndrome</keyword>
  <keyword>Pre-diabetes</keyword>
  <keyword>impaired glucose tolerance</keyword>
  <keyword>Phospholipids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

